Skip to main content

Apoptosome Pharmacological Manipulation: From Current Developments in the Laboratory to Clinical Implications

  • Chapter
  • First Online:
Apoptosome

Abstract

Apoptosis is a topic of pressing scientific interest which includes the study of mechanisms involved in programmed cell death. The key role of apoptosome in various pathological processes suggests that the pharmacology of apoptosome will become equally important to pharmaceutical companies. Indeed, as described in previous chapters, emerging knowledge about the proteins which constitute the apoptotic machinery together with the definition of molecular structure of apoptosome complex have revealed new potential therapeutic strategies. In the following chapters, besides providing a synopsis of the Translational Research and Drug Discovery Process, we will survey antiapoptotic drug therapy, in different clinical phases, aimed at interrupting or attenuating various pathogenic pathways of disease and/or at ameliorating symptoms.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Bachurin SO, Shevtsova EP, Kireeva EG, Oxenkrug GF, Sablin SO (2003). Mitochondria as a target for neurotoxins and neuroprotective agents. Ann NY Acad Sci. 993, 334–44.

    Google Scholar 

  • Benatar M (2007). Lost in translation: treatment trials in the SOD1 mouse and in human ALS. Neurobiol Dis. 26, 1–13.

    Google Scholar 

  • Klivenyi P, Ferrante RJ, Matthews RT, Bogdanov MB, Klein AM, Andreassen OA, Mueller G, Wermer M, Kaddurah-Daouk R, Beal MF.(1999) Neuroprotective effects of creatine in a transgenic animal model of amyotrophic lateral sclerosis. Nat Med. 5, 347–50.

    Google Scholar 

  • Kristal BS and Krasnikov BF. (2003) Structure-(Dys)function relationships in mitochondrial electron transport chain complex II? Sci Aging Knowledge Environ 5, PE3.

    Google Scholar 

  • LeBlanc AC (2005). The role of apoptotic pathways in Alzheimer’s disease neurodegeneration and cell death. Curr Alzheimer Res.2, 389–402.

    Google Scholar 

  • Luchsinger JA, Tang MX, Siddiqui M, Shea S, Mayeux R. (2004). Alcohol intake and risk of dementia. J Am Geriatr Soc. 52, 540–6.

    Google Scholar 

  • Miller NJ, Rice-Evans CA. (1995) Antioxidant activity of resveratrol in red wine. Clin Chem. 41 (12 Pt 1):1789.

    Google Scholar 

  • Ramalho RM, Borralho PM, Castro RE, Sola S, Steer CJ, Rodrigues CM. (2006) Tauroursode­oxycholic acid modulates p53-mediated apoptosis in Alzheimer’s disease mutant neuroblastoma cells. J Neurochem. 98, 1610–8.

    Google Scholar 

  • Rodrigues CM, Sola S, Nan Z, Castro RE, Ribeiro PS, Low WC, Steer CJ. (2003) Tauroursodeoxycholic acid reduces apoptosis and protects against neurological injury after acute hemorrhagic stroke in rats. Proc Natl Acad Sci USA.100:6087–92.

    Google Scholar 

  • Sathasivam S, Shaw PJ (2005). Apoptosis in amyotrophic lateral sclerosis--what is the evidence? Lancet Neurol. 4, 500–9.

    Google Scholar 

  • Schild L and Reiser G. (2005) Oxidative stress is involved in the permeabilization of the inner membrane of brain mitochondria exposed to hypoxia/reoxygenation and low micromolar Ca2+. FEBS J. 272, 3593–601.

    Google Scholar 

  • Schulz JB. (2008). Update on the pathogenesis of Parkinson’s disease. J Neurol. 255 Suppl 5:3–7.

    Google Scholar 

  • Su B, Wang X, Nunomura A, Moreira PI, Lee HG, Perry G, Smith MA, Zhu X. (2008) Oxidative stress signaling in Alzheimer’s disease. Curr Alzheimer Res. 5, 525–32.

    Google Scholar 

  • Suno M, Nagaoka A. (1989) Inhibition of brain mitochondrial swelling by idebenone. Arch Gerontol Geriatr. 8, 299–305.

    Google Scholar 

  • Tauskela JS. (2007) MitoQ-a mitochondria-targeted antioxidant. IDrugs.10, 399–412.

    Google Scholar 

  • Truelsen T, Thudium D, Grønbaek M; Copenhagen City Heart Study (2002). Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology. 59, 1313–9.

    Google Scholar 

  • Wu J, Li Q, Bezprozvanny I. (2008) Evaluation of Dimebon in cellular model of Huntington’s Disease. Mol Neurodegener. 21, 3–15.

    Google Scholar 

  • Zhu YG, Chen XC, Chen ZZ, Zeng YQ, Shi GB, Su YH, Peng X. (2004) Curcumin protects mitochondria from oxidative damage and attenuates apoptosis in cortical neurons. Acta Pharmacol Sin. 25, 1606–12.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Marcello D’Amelio .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2010 Springer Science+Business Media B.V.

About this chapter

Cite this chapter

D’Amelio, M., Cecconi, F. (2010). Apoptosome Pharmacological Manipulation: From Current Developments in the Laboratory to Clinical Implications. In: Cecconi, F., D'Amelio, M. (eds) Apoptosome. Springer, Dordrecht. https://doi.org/10.1007/978-90-481-3415-1_14

Download citation

Publish with us

Policies and ethics